← Back to Clinical Trials
Recruiting NCT07463105

NCT07463105 Virtual Reality-Based Rehabilitation Versus Conventional Therapy in Patients With Chronic Low Back Pain

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07463105
Status Recruiting
Phase —
Sponsor University of Rzeszow
Condition Chronic Low Back Pain
Study Type INTERVENTIONAL
Enrollment 80 participants
Start Date 2026-04-01
Primary Completion 2027-04-30

Eligibility & Interventions

Sex All sexes
Min Age 40 Years
Max Age 65 Years
Study Type INTERVENTIONAL
Interventions
Virtual Reality-Assisted RehabilitationConventional Rehabilitation

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 80 participants in total. It began in 2026-04-01 with a primary completion date of 2027-04-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study aims to evaluate the effectiveness of rehabilitation using virtual reality compared with conventional physiotherapy in patients with chronic low back pain. The study will be conducted as a prospective, randomized controlled trial including 80 patients aged 40-65 years diagnosed with chronic low back pain lasting at least three months. Participants will be randomly assigned to two groups: an experimental group receiving conventional rehabilitation supplemented with non-immersive virtual reality training using the Tecnobody Homing Studio system, and a control group receiving conventional rehabilitation alone. Both groups will participate in a four-week rehabilitation program. The virtual reality training will replace a portion of conventional exercises and will focus on improving movement quality, postural control, coordination, and functional mobility through interactive tasks with visual and auditory biofeedback. The system utilizes a 3D camera enabling markerless motion analysis and real-time visual feedback to support movement correction and identification of functional deficits. Outcome measures will include assessments of balance, posture, joint mobility, lower limb strength and endurance, pain intensity, pressure pain threshold, kinesiophobia, perceived stress, anxiety and depression, functional disability, quality of life, and motivation for physical activity. Measurements will be conducted at baseline, immediately after completion of the four-week rehabilitation program, and at an eight-week follow-up. The results of this study are expected to provide clinical evidence regarding the effectiveness of virtual reality-assisted rehabilitation in patients with chronic low back pain and may contribute to the development of evidence-based rehabilitation strategies incorporating digital technologies.

Eligibility Criteria

Inclusion Criteria: * Diagnosis of chronic low back pain lasting at least 3 months * Average pain intensity ≥4/10 during the previous week on the Numeric Rating Scale (NRS) * Age between 40 and 65 years * Ability to walk independently without assistive devices * Functional disability related to low back pain defined as Oswestry Disability Index (ODI) ≥15% * No contraindications to participation in a physiotherapy program or virtual reality training * Ability to understand study procedures and follow instructions * Written informed consent to participate in the study Exclusion Criteria: * Acute low back pain or pain lasting less than 3 months * Neurological, orthopedic, rheumatological, oncological diseases or active inflammatory conditions that may affect study outcomes * Cognitive impairment limiting the ability to understand instructions or participate in rehabilitation * Contraindications to virtual reality training such as severe dizziness, nausea, epilepsy, or severe visual or auditory impairment * Contraindications to body composition analysis (e.g., implanted cardiac pacemaker or other electronic implants) * Unstable medical condition or uncontrolled cardiovascular or respiratory disorders preventing participation in rehabilitation * Participation in other rehabilitation programs during the study period * Failure to complete the four-week rehabilitation program * Lack of written informed consent

Contact & Investigator

Central Contact

Michal Pastyrzak

✉ michalpastyrzak@gmail.com

📞 +48 664221066

Principal Investigator

Michal Pastyrzak

PRINCIPAL INVESTIGATOR

University of Rzeszow

Frequently Asked Questions

Who can join the NCT07463105 clinical trial?

This trial is open to participants of all sexes, aged 40 Years or older, up to 65 Years, studying Chronic Low Back Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07463105 currently recruiting?

Yes, NCT07463105 is actively recruiting participants. Contact the research team at michalpastyrzak@gmail.com for enrollment information.

Where is the NCT07463105 trial being conducted?

This trial is being conducted at Sanok, Poland.

Who is sponsoring the NCT07463105 clinical trial?

NCT07463105 is sponsored by University of Rzeszow. The principal investigator is Michal Pastyrzak at University of Rzeszow. The trial plans to enroll 80 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology